[go: up one dir, main page]

AR008908A1 - USE OF LORATADINE AND A DECOARANT TO PREPARE A MEDICATION TO IMPROVE THE LUNG FUNCTION OF A PATIENT WITH ASTHMA - Google Patents

USE OF LORATADINE AND A DECOARANT TO PREPARE A MEDICATION TO IMPROVE THE LUNG FUNCTION OF A PATIENT WITH ASTHMA

Info

Publication number
AR008908A1
AR008908A1 ARP970105033A ARP970105033A AR008908A1 AR 008908 A1 AR008908 A1 AR 008908A1 AR P970105033 A ARP970105033 A AR P970105033A AR P970105033 A ARP970105033 A AR P970105033A AR 008908 A1 AR008908 A1 AR 008908A1
Authority
AR
Argentina
Prior art keywords
loratadine
improve
asthma
lung function
patient
Prior art date
Application number
ARP970105033A
Other languages
Spanish (es)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR008908A1 publication Critical patent/AR008908A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Uso de loratadina y un discongestivo para la manufactura de un medicamento para mejorar la funcion pulmonar de un paciente que padece asma, en dondeel medicamento contiene para la rinitis, cantidades efectivas de loratadina para el tratamientod e renitis usual y de un descongestivo. Dicho descongestivopuede estar seleccionado del grupo formado por fenilpropanolamina, efedrina, psendoefedrina o una combinacion de las mismas.Use of loratadine and a decongestant for the manufacture of a medicine to improve the lung function of an asthma patient, where the medicine contains for rhinitis effective amounts of loratadine for the treatment of usual renitis and a decongestant. Said decongestant may be selected from the group consisting of phenylpropanolamine, ephedrine, psendoephedrine, or a combination thereof.

ARP970105033A 1996-10-31 1997-10-29 USE OF LORATADINE AND A DECOARANT TO PREPARE A MEDICATION TO IMPROVE THE LUNG FUNCTION OF A PATIENT WITH ASTHMA AR008908A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31

Publications (1)

Publication Number Publication Date
AR008908A1 true AR008908A1 (en) 2000-02-23

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105033A AR008908A1 (en) 1996-10-31 1997-10-29 USE OF LORATADINE AND A DECOARANT TO PREPARE A MEDICATION TO IMPROVE THE LUNG FUNCTION OF A PATIENT WITH ASTHMA

Country Status (21)

Country Link
EP (1) EP0941091A1 (en)
JP (1) JP2000505104A (en)
KR (1) KR20000052922A (en)
CN (1) CN1235545A (en)
AR (1) AR008908A1 (en)
AU (1) AU731756B2 (en)
BR (1) BR9712705A (en)
CA (1) CA2268546A1 (en)
CO (1) CO4910128A1 (en)
CZ (1) CZ150999A3 (en)
HU (1) HUP9904075A3 (en)
ID (1) ID23431A (en)
IL (1) IL129662A0 (en)
NO (1) NO992062D0 (en)
NZ (1) NZ335078A (en)
PE (1) PE11399A1 (en)
PL (1) PL333056A1 (en)
SK (1) SK54599A3 (en)
TR (1) TR199901003T2 (en)
WO (1) WO1998018470A1 (en)
ZA (1) ZA979731B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1205799A (en) * 1997-10-29 1999-05-17 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (en) * 1998-07-28 2001-02-23 Nicox Sa SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM
WO2000015226A1 (en) * 1998-09-10 2000-03-23 Schering Corporation Antihistamines for treating non-infective sinusitis or otitis media
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
EP1154762B1 (en) * 1999-02-23 2003-11-05 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
KR100505899B1 (en) * 1999-02-23 2005-08-01 주식회사유한양행 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
SK287105B6 (en) * 1999-12-20 2009-12-07 Schering Corporation Bilayer sustained release oral dosage composition
SK287684B6 (en) * 1999-12-20 2011-06-06 Schering Corporation Sustained release solid oral pharmaceutical dosage composition
CA2405238C (en) * 2000-04-14 2014-03-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
WO2001089527A2 (en) * 2000-05-24 2001-11-29 Schering Corporation Pharmaceutical composition comprising loratadine and a nasal decongestant
HUP0401630A2 (en) * 2001-06-20 2004-12-28 Schering Corp. Antihistamines use of for preparation of pharmaceutical compositions suitable for the treatment of nasal congestion and nasal obstruction
RU2423979C2 (en) * 2005-06-17 2011-07-20 АФТ Фармасьютикалз Лимитед Novel pharmaceutic composition and its application in method of treatment of patients with hyperaemia and edema of mucous membrane of upper airways
CA2612179C (en) 2005-06-17 2016-08-02 Aft Pharmaceuticals Limited A pharmaceutical composition comprising loratadine and its use to treat patients with upper respiratory mucosal congestion
CL2007001584A1 (en) * 2006-06-01 2008-01-25 Msd Consumer Care Inc Pharmaceutical composition comprising: a nucleus with phenylephrine in the form of immediate release and an erodible layer comprising phenylephrine and a sustained-release matrix; Useful to treat symptoms of cold, influenza, allergies or non-allergic rhinitis.
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (en) * 2014-02-24 2015-07-28 성균관대학교산학협력단 Composition comprising Loratadine for anti-inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
NO992062L (en) 1999-04-29
NO992062D0 (en) 1999-04-29
CZ150999A3 (en) 1999-10-13
HUP9904075A2 (en) 2000-05-28
NZ335078A (en) 2000-10-27
PL333056A1 (en) 1999-11-08
CA2268546A1 (en) 1998-05-07
ID23431A (en) 2000-04-20
KR20000052922A (en) 2000-08-25
AU4995397A (en) 1998-05-22
AU731756B2 (en) 2001-04-05
ZA979731B (en) 1998-04-29
IL129662A0 (en) 2000-02-29
CO4910128A1 (en) 2000-04-24
CN1235545A (en) 1999-11-17
JP2000505104A (en) 2000-04-25
PE11399A1 (en) 1999-02-09
SK54599A3 (en) 2000-08-14
TR199901003T2 (en) 1999-07-21
HUP9904075A3 (en) 2002-02-28
WO1998018470A1 (en) 1998-05-07
BR9712705A (en) 1999-10-26
EP0941091A1 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
AR008908A1 (en) USE OF LORATADINE AND A DECOARANT TO PREPARE A MEDICATION TO IMPROVE THE LUNG FUNCTION OF A PATIENT WITH ASTHMA
CL2008003938A1 (en) Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).
AR026610A1 (en) A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
CL2004000675A1 (en) USE OF A ANDROGEN COMBINATION OF BIOGENIC OR SYNTHETIC ORIGIN AND A BIOGENIC OR SYNTHETIC ORIGIN STROGEN TO PREPARE A USEFUL MEDICINAL PRODUCT IN THE TREATMENT OF HYPOGONADISM AND PITUITARIAN HYPOPHISIS OR GLAND DISEASES FOR MEN
AR005281A1 (en) ORAL PHARACEUTICAL COMPOSITION, PROCEDURES FOR ITS MANUFACTURE AND USE OF THAT PHARMACEUTICAL COMPOSITION FOR THE PREPARATION OF MEDICINES. .
AR013742A1 (en) METHOD FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA WITH NON-SUBSTITUTED POLIDIALILAMINE
CL2009001279A1 (en) Nociceptin derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of pain (sol. divisional 2103-03).
CO4520286A1 (en) PROCEDURE FOR PREPARING 1- (2-DEXESOXY-2, 2-DIFLUORO-D-RIBOFURANOSIL) -4-AMINOPYRIMIDIN-2-ONA
AR005282A1 (en) ORAL PHARMACEUTICAL COMPOSITION IN THE FORM OF A TABLET OF MULTIPLE UNITS, USE OF THE SAME FOR THE PREPARATION OF MEDICINES, AND PROCEDURE FOR ITS MANUFACTURE.
NO990522L (en) Use of <beta> -sheet mimetics as protease and kinase inhibitors of transcription factors
AR011106A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF DIABETES MELLITUS TYPE 2,
ES2167401T3 (en) USE OF ASCORBIL-GAMMA-LINOLENATE OR ASCORBIL-DIHOMO-GAMMA-LINOLENATE FOR THE TREATMENT OF ASTHMA, CANCER, CARDIOVASCULAR DISEASES AND ANTI-INFLAMMATORIES.
BR0107628A (en) 1,2-diarylbenzimidazoles for treating diseases that are associated with microglial activation
ES2188995T3 (en) USE OF AN INHIBITOR OF THE H +, K + -ATPASA IN THE TREATMENT OF NASAL POLYPS.
ATE451934T1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RHINITIDES
DE68915503D1 (en) Dental surgical device, suitable for the supply of coupled handpieces with three different fluids.
NO972433D0 (en) Substituted 2-naphthoylguanidines, processes for their preparation, their use as a drug or diagnostic, and medicaments containing the compounds
IT1317930B1 (en) USE OF LONG PENTRAXIN PTX3 FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF PATALOGIES ASSOCIATED WITH AN ALTERED ACTIVATION
ES2191206T3 (en) NEW USE OF CREATINE.
BR0015781A (en) Pharmaceutical composition for treatment of diseases associated with decreased bone mass
AR018376A1 (en) PHARMACEUTICAL COMPOSITIONS THAT CAN BE DISPERSED IN A SPONTANEOUS WAY AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
AR014082A1 (en) ORAL SERTRALINE CONCENTRATE
CL2004001291A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES CARBOCICLIC AND HETEROCICLIC COMPOUNDS; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF INFLUENZA INFECTION.
NO972434L (en) Substituted 1-Naphthoylguanidines, Methods of Preparation thereof, Their Use as a Drug or Diagnostic, and Medicines Containing the Compounds
ES2069030T3 (en) METHOD FOR DEALING WITH DEFECTIVE HEART OPERATION.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal